The relationship of metalloproteinase gene polymorphisms and lung cancer

Journal of Surgical Research

Volumn 183, Issue 2, 2013, Pages 517-523

  Sanli, Maruf ^a   Akar, Erkan ^a   Pehlivan, Sacide ^a   Bakir, Kemal ^a   Tuncozgur, Bulent ^a   Isik, Ahmet Feridun ^a   Pehlivan, Mustafa ^a   Elbeyli, Levent ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Expression; Lung cancer; Matrix metalloproteinases; Polymorphism

Indexed keywords

COLLAGENASE 3; DNA; GELATINASE A; MATRILYSIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CANCER PROGNOSIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EXPRESSION; LUNG CANCER; MATRIX METALLOPROTEINASES; POLYMORPHISM;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS;

EID: 84880297217     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.01.045     Document Type: Article

References (21)

1. B.W. Ennis, and L.M. Matrisian Matrix degrading metalloproteinases J Neurooncol 18 1994 105
2. P.T. Elkington, and J.S. Friedland Matrix metalloproteinases in destructive pulmonary pathology Thorax 61 2006 259
3. C.M. Hartog, J.A. Wermelt, C.O. Sommerfeld, W. Eichler, K. Dalhoff, and J. Braun Pulmonary matrix metalloproteinase excess in hospital-acquired pneumonia Am J Respir Crit Care Med 167 2003 593
4. C. Yu, Y. Zhou, X. Miao, P. Xiong, W. Tan, and D. Lin Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer Cancer Res 64 2004 7622
5. S. Ye, N. Patodi, K. Walker-Bone, I. Reading, C. Cooper, and E. Dennison Variation in the matrix metalloproteinase-3, -7, -12 and -13 genes is associated with functional status in rheumatoid arthritis Int J Immunogenet 34 2007 81
6. Y. Li, J.H. Jia, and S. Kang The functional polymorphisms on promoter region of matrix metalloproteinase-12, -13 genes may alter the risk of epithelial ovarian carcinoma in Chinese Int J Gynecol Cancer 19 2009 129
7. J.L. Mulshine Reducing lung cancer risk: early detection Chest 116 1999 493S
8. M. Fleischhacker, T. Beinert, and K. Possinger Molecular genetic characteristics of lung cancer - useful as real tumor markers? Lung Cancer 25 1999 7
9. Z.D. Gu, J.Y. Li, and M. Li Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma Am J Gastroenterol 100 2005 1835
10. J.M. Freije, I. Díez-Itza, and M. Balbín Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas J Biol Chem 269 1994 16766
11. C. Yu, K. Pan, and D. Xing Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer Cancer Res 62 2002 6430
12. B. Passlick, W. Sienel, and R. Seen-Hibler Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer Clin Cancer Res 6 2000 3944
13. J. Rollin, S. Régina, and P. Vourc'h Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer Lung Cancer 56 2007 273
14. Y. Zhou, C. Yu, and X. Miao Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility Carcinogenesis 26 2005 1117
15. U.K. Saarialho-Kere, E.C. Crouch, and W.C. Parks Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium J Invest Dermatol 105 1995 190
16. N. Holler, A. Tardivel, and M. Kovacsovics-Bankowski Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex Mol Cell Biol 23 2003 1428
17. J. Zhang, X. Jin, and S. Fang The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma Carcinogenesis 26 2005 1748
18. G. Ghilardi, M.L. Biondi, M. Erario, E. Guagnellini, and R. Scorza Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms Clin Chem 49 2003 1940
19. H. Sasaki, H. Yukiue, and S. Moiriyama Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer J Surg Res 101 2001 242
20. P. González-Arriaga, M.F. López-Cima, and A. Fernández-Somoano Polymorphism +17 C/G in matrix metalloprotease MMP8 decreases lung cancer risk BMC Cancer 8 2008 378
21. C.P. Hsu, G.H. Shen, and J.L. Ko Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer Lung Cancer 52 2006 349